Stay updated on CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial

Sign up to get notified when there's something new on the CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page has removed a reference to an erratum related to a phase III trial of tirasemtiv for amyotrophic lateral sclerosis.
    Difference
    0.3%
    Check dated 2025-05-08T09:54:20.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T05:10:55.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant updates, including the removal of detailed study information regarding CK-2127107 (reldesemtiv) for ALS, while adding new references to collaborators and a revision update.
    Difference
    21%
    Check dated 2025-04-16T14:35:04.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T09:23:19.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.2%
    Check dated 2025-04-01T23:24:25.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-03-25T13:52:19.000Z thumbnail image

Stay in the know with updates to CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial page.